Johnson & Johnson Innovation - JJDC, Inc.
CIK 924020 · last filed 2026-01-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$28.81M
Companies
7
Total Filings
20
Lifetime Open-Market Net
-$90.70M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CVRX | 10%+ Owner | 4,024,861 | $4.74 | $19.08M | -$660.4K | 6 | 2026-01-08 |
| MGTX | 10%+ Owner | 0 | $11.77 | $0 | $0 | 1 | 2023-09-18 |
| INSP | 10%+ Owner | 197,863 | $49.19 | $9.73M | $0 | 1 | 2018-05-07 |
| NERV | 10%+ Owner | 0 | $4.04 | $0 | $0 | 1 | 2017-09-14 |
| NEVRO CORP (NVRO) Delisted | 10%+ Owner | 2,066,740 | $5.84 | $12.07M | -$95.42M | 2 | 2015-06-08 |
| Neurogene Inc. (AQXP) Delisted | 10%+ Owner | 1,664,821 | — | — | $5.38M | 7 | 2015-02-03 |
| GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | 10%+ Owner | 173,581 | $0.00 | $104 | $0 | 1 | 2014-02-11 |
Recent Filings · Page 2 of 2
20 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-06-08 | NEVRO CORP (NVRO) Delisted | Sell (S) | −2,020,530 | -$96.86M | EDGAR |
| 2015-02-03 | Neurogene Inc. (AQXP) Delisted | Mixed | +3,329,642 | $6.00M | EDGAR |
| 2014-12-18 | Neurogene Inc. (AQXP) Delisted | Sell (S) | −16,200 | -$123.4K | EDGAR |
| 2014-12-15 | Neurogene Inc. (AQXP) Delisted | Sell (S) | −10,000 | -$75.1K | EDGAR |
| 2014-12-05 | Neurogene Inc. (AQXP) Delisted | Sell (S) | −31,800 | -$246.9K | EDGAR |
| 2014-12-03 | Neurogene Inc. (AQXP) Delisted | Sell (S) | −2,400 | -$18.1K | EDGAR |
| 2014-11-24 | Neurogene Inc. (AQXP) Delisted | Sell (S) | −19,000 | -$154.7K | EDGAR |
| 2014-11-12 | NEVRO CORP (NVRO) Delisted | Mixed | +6,154,010 | $1.44M | EDGAR |
| 2014-03-12 | Neurogene Inc. (AQXP) Delisted | Conv (C) | +2,784,188 | $0 | EDGAR |
| 2014-02-11 | GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Conv (C) | +2,777,290 | $0 | EDGAR |
Showing 11–20 of 20
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.